z-logo
open-access-imgOpen Access
[Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
Author(s) -
Dongjie Ma,
Shanqing Li,
Yushang Cui,
Li Li,
Hongsheng Liu,
Yeye Chen,
Xiaoyun Zhou
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12480
Subject(s) - oncogene , paclitaxel , pi3k/akt/mtor pathway , cancer , molecular medicine , protein kinase b , cell cycle , cancer research , lung cancer , apoptosis , cell , sensitivity (control systems) , medicine , chemistry , oncology , biochemistry , engineering , electronic engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom